EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Long non-coding RNAs in schizophrenia: Genetic variations, treatment markers and potential targeted signaling pathways

Ting Cao, ShuangYang Zhang, Qian Chen, CuiRong Zeng, LiWei Wang, ShiMeng Jiao, Hui Chen, BiKui Zhang, HuaLin Cai

Schizophrenia Research · 2023

DOI: 10.1016/j.schres.2023.07.027 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Schizophrenia Research, 2023. Verfasst von Ting Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Institute of Clinical Pharmacy, Second Xiangya Hos…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Schizophrenia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 148 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schizophrenia (SZ), a complex and debilitating spectrum of psychiatric disorders, is now mainly attributed to multifactorial etiology that includes genetic and environmental factors. Long non-coding RNAs (lncRNAs) are gaining popularity as a way to better understand the comprehensive mechanisms beneath the clinical manifestation of SZ. Only in recent years has it been elucidated that mammalian genomes encode thousands of lncRNAs. Strikingly, roughly 30-40% of these lncRNAs are extensively expressed in different regions across the brain, which may be closely associated with SZ. The therapeutic and adverse effects of atypical antipsychotic drugs (AAPDs) are partially reflected by their role in the regulation of lncRNAs. This begs the question directly, do any lncRNAs exist as biomarkers for AAPDs treatment? Furthermore, we comprehend a range of mechanistic investigations that have revealed the regulatory roles for lncRNAs both involved in the brain and the periphery of SZ. More crucially, we also combine insights from a variety of signaling pathways to argue that lncRNAs probably play critical roles in SZ via their interactive downstream factors. This review provides a thorough understanding regarding dysregulation of lncRNAs, corresponding genetic alternations, as well as their potential regulatory roles in the pathology of SZ, which might help reveal useful therapeutic targets in SZ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingSchizophreniaAnimalsHumansBiomarkersSignal TransductionGenetic VariationMammals

Stichwörter der Autor:innen

DysregulationInteractive factorsLncRNASZTreatment response

Substanzen

RNA, Long NoncodingBiomarkers

Autor:innen und Institutionen

  • Department of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Institute of Clinical Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Xiangya Schoo…
  • Department of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Institute of Clinical Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Institute of Clinical Pharmacy, Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Electronic ad…

Zitieren

APA

Cao, T., Zhang, S., Chen, Q., Zeng, C., Wang, L., Jiao, S., Chen, H., Zhang, B., & Cai, H. (2023). Long non-coding RNAs in schizophrenia: Genetic variations, treatment markers and potential targeted signaling pathways. Schizophrenia Research. https://doi.org/10.1016/j.schres.2023.07.027

Vancouver

Cao T, Zhang S, Chen Q, Zeng C, Wang L, Jiao S, et al. Long non-coding RNAs in schizophrenia: Genetic variations, treatment markers and potential targeted signaling pathways. Schizophrenia Research. 2023. doi:10.1016/j.schres.2023.07.027

BibTeX
@article{Cao2023,
  author = {Cao, Ting and Zhang, ShuangYang and Chen, Qian and Zeng, CuiRong and Wang, LiWei and Jiao, ShiMeng and Chen, Hui and Zhang, BiKui and Cai, HuaLin},
  title = {Long non-coding RNAs in schizophrenia: Genetic variations, treatment markers and potential targeted signaling pathways},
  journal = {Schizophrenia Research},
  year = {2023},
  doi = {10.1016/j.schres.2023.07.027}
}
Kostenlos starten →